Cryogenic storage and freezing demands have demonstrated continual and incremental growth over the years due to healthcare advances, improved quality of life, and longer lifespans, with the majority of samples in medical and pharmaceutical applications passing through the cold chain and typically requiring cold storage and cryogenic freezing at some point.
As Andy Pazahanick, General Manager of Worthington Industries’ CryoScience product line, points out, “According to a 2014 study by Visiongain, it’s estimated that there are 1.3 billion bio samples in the life sciences market worldwide – and it is growing by 100 million bio samples each year. These samples are extracted, processed, analysed, stored and shipped in the cold storage chain.”
So how is cryogenic freezing and cold storage in the cold chain advancing, and what new products are being developed to keep up with its expanding demand capacity? This month’s In Focus…explores the growth drivers in the sector and the new techniques that companies are implementing to freeze out their competition.
... to continue reading you must be subscribed
